5-amino-1mq and cd38 inhibitor synergy nad+ Rapid Discovery of via DNA-Encoded Natural Product Library Screening The Pharmacology of CD38/NADase: An
The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice Scientific Reports Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target Nicotinamide N methyltransferase as a potential therapeutic target for neurodegenerative disorders: Mechanisms, challenges, and future directions ScienceDirect
Pay in 4 interest-free payments of $5.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22



